Prior to co-founding CRIO, Raymond owned and operated a clinical research site. He has over 10 years of management consulting experience, including The Boston Consulting Group. He also started Bench Core, a real estate data analytics company that was acquired by RefineRE. He began his career as an attorney and has JD and BA degrees from Harvard...
Margaretta Nyilas is a biopharmaceutical executive with over twenty years of diverse, global industry experience. Most recently, Ms. Nyilas acted as a Member of the Board of Directors of Otsuka Europe Development & Commercialization, Ltd. and as a Chief Medical Officer with Click Therapeutics. She currently serves as a Board Member of Pharmavite LLC (an...
Tom Peterson has been a venture capitalist for more than 30 years and is a veteran early-stage technology investor, focusing on enterprise software and infrastructure companies. Tom joined Rally Ventures at its inception in 2012 as Venture Partner. Peterson was one of the founding members of El Dorado Ventures and also serves on the boards...
Mr. Jeffrey Stein serves as the CEO and president of ALSA Research, a limited liability company he founded in 2007 when he purchased Stamford Therapeutics Consortium a dedicated research site located in Stamford CT. In 2015 ALSA acquired a second site, New England Research Associates, from its founder, Dr. Geoffrey Gladstein. ALSA has been an...
Mr. Roome manages investments in healthcare and technology-enabled pharmaceutical services. In addition to his role at CRIO, Mr. Roome serves as a board member or observer at: BEK Health, Kaid Health, OrbitalRx, Precision Digital Health, and Reveleer. Mr. Roome joined Boston Millennia Partners after completing a Masters of International Business at the Fletcher School of...
